Shareholders might have noticed that Rakus Co., Ltd. (TSE:3923) filed its full-year result this time last week. The early response was not positive, with shares down 7.5% to JP¥832 in the past week. Rakus reported JP¥60b in revenue, roughly in line with analyst forecasts, although statutory earnings per share (EPS) of JP¥36.91 beat expectations, being 2.2% higher than what the analysts expected. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. So we gathered the latest post-earnings forecasts to see what estimates suggest is in store for next year.

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.

Taking into account the latest results, Rakus' six analysts currently expect revenues in 2027 to be JP¥61.5b, approximately in line with the last 12 months. Statutory earnings per share are predicted to surge 88% to JP¥71.70. Before this earnings report, the analysts had been forecasting revenues of JP¥61.8b and earnings per share (EPS) of JP¥70.49 in 2027. So it's pretty clear that, although the analysts have updated their estimates, there's been no major change in expectations for the business following the latest results.

Check out our latest analysis for Rakus

It will come as no surprise then, to learn that the consensus price target is largely unchanged at JP¥1,092. There's another way to think about price targets though, and that's to look at the range of price targets put forward by analysts, because a wide range of estimates could suggest a diverse view on possible outcomes for the business. The most optimistic Rakus analyst has a price target of JP¥1,450 per share, while the most pessimistic values it at JP¥800. Analysts definitely have varying views on the business, but the spread of estimates is not wide enough in our view to suggest that extreme outcomes could await Rakus shareholders.

Taking a look at the bigger picture now, one of the ways we can understand these forecasts is to see how they compare to both past performance and industry growth estimates. We would highlight that Rakus' revenue growth is expected to slow, with the forecast 1.9% annualised growth rate until the end of 2027 being well below the historical 27% p.a. growth over the last five years. Compare this against other companies (with analyst forecasts) in the industry, which are in aggregate expected to see revenue growth of 9.9% annually. So it's pretty clear that, while revenue growth is expected to slow down, the wider industry is also expected to grow faster than Rakus.

The Bottom Line

The most important thing to take away is that there's been no major change in sentiment, with the analysts reconfirming that the business is performing in line with their previous earnings per share estimates. Fortunately, the analysts also reconfirmed their revenue estimates, suggesting that it's tracking in line with expectations. Although our data does suggest that Rakus' revenue is expected to perform worse than the wider industry. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates.

Following on from that line of thought, we think that the long-term prospects of the business are much more relevant than next year's earnings. We have estimates - from multiple Rakus analysts - going out to 2029, and you can see them free on our platform here.

However, before you get too enthused, we've discovered 1 warning sign for Rakus that you should be aware of.